Hematology/Oncology

Top Story

FDA grants accelerated approval to Keytruda for solid tumors with specific biomarker

May 23, 2017

The FDA today granted accelerated approval to pembrolizumab for adults and children with unresectable or metastatic, microsatellite instability–high or mismatch repair–deficient solid tumors.

This indication for pembrolizumab (Keytruda, Merck) — the FDA’s first tissue/site-agnostic approval — includes patients with solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options, as well as patients with colorectal cancer that has progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.

Federal budget proposal would deal ‘devastating blow’ to medical research

May 23, 2017
The Trump administration’s proposed 2018 budget would decimate scientific research and innovation while jeopardizing millions of Americans’ access to…

ACP offers recommendations to Congress for health care reform

May 23, 2017
Today, the ACP released a new policy agenda containing several recommendations for Congress to improve American health care. The paper, titled A Prescription for a
In the Journals

Heated cigarettes release same cancer-causing chemicals as traditional cigarettes

May 23, 2017
Smoke released from heat-not-burn tobacco cigarettes contains the same harmful components as conventional tobacco cigarette smoke, according to data published in JAMA

One alcoholic drink per day increases breast cancer risk

May 23, 2017
Women who consume one alcoholic drink per day are at elevated risk for breast cancer, according to a report from the World Cancer Research Fund and American Institute…
More News Headlines »
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Video
Meeting News

VIDEO: Gene mutation analysis an ‘important piece’ of melanoma diagnosis

April 3, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement